Navigation Links
LIVESTRONG and Penn Medicine announce partnership to bring online care plan tool to cancer survivors

AUSTIN, Texas; PHILADELPHIA The Lance Armstrong Foundation (LAF) and Penn Medicine announced today a four-year partnership to further develop and disseminate the LIVESTRONG Care Plan Powered by Penn Medicine's OncoLink. This free service gives cancer survivors, their families and physicians the ability to create an individualized plan of care using up-to-date treatment information based on Institute of Medicine recommendations, as well educating them about their options to maintain optimal health once they are out of treatment.

The LIVESTRONG Care Plan assists adults diagnosed with cancer in understanding and planning for such issues as: potential late effects of treatment; recommendations for cancer screening (recurrence or new primary); psychosocial effects (including relationships and sexuality/fertility); recommendations for a healthy lifestyle; genetic counseling (if appropriate); effective prevention options; and a list of resources made available through the LIVESTRONG cancer survivorship support services.

"There are currently 12 million cancer survivors in the United States and 28 million worldwide," said Doug Ulman, President and CEO of the Lance Armstrong Foundation. "The lack of post-cancer medical care leaves a staggering number of people without support. The LIVESTRONG Care Plan is a simple, easily accessible resource to help people manage the ongoing effects of cancer treatments, communicate with their medical team and get the support they need in all aspects of their fight."

Originally launched as OncoLife on Penn Medicine's OncoLink website in 2007, the tool is the only one of its kind, created and updated continuously by a team of cancer physicians and nurses. With its transition to the LIVESTRONG Care Plan, it will be able to reach tens of thousands of additional cancer survivors, their friends, families and health care providers through the LAF's many supportive activities and programs. Available in Spanish as well as English, the LIVESTRONG Care Plan is designed to also help facilitate a meaningful discussion between cancer survivors and their health care providers. For example, the care plan provides users with a report outlining medical tests survivors should discuss with their physician once they have completed active treatment.

"The LIVESTRONG Care Plan empowers cancer survivors to take an active role in their health care by providing customized information based on the cancer therapies they receive," said James M. Metz, MD., associate professor at Penn Medicine's Department of Radiation Oncology and Editor-in-Chief of OncoLink. "This unique tool allows them to open meaningful dialog with their healthcare team to assist them in their continued journey through cancer survivorship."

The LAF's interest in providing a state-of-the-art care plan through its Network reaches back to 2006 and the first meeting of the LIVESTRONG Survivorship Center of Excellence Network which identified the need for a care plan through which cancer survivors could document important milestones in their cancer experiences. The benefit of cancer survivorship care plans was embraced by an Institute of Medicine report, "From Cancer Patient to Cancer Survivor: Lost in Transition" in November, 2005.

Today's announcement of a partnership between LAF and Penn Medicine supports the mission of both entities to provide cancer survivors around the world an easy and accessible way for them to take charge and optimize the quality of their lives.


Contact: Marc Kaplan
University of Pennsylvania School of Medicine

Related medicine news :

1. Lance Armstrong Marks 5th Annual LIVESTRONG(TM) Day with Nationwide Fly-Around
2. LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful
3. Lance Armstrong Foundation and Demand Media Launch LIVESTRONG.COM
4. Lance Armstrong Foundation to Welcome Senator John McCain to LIVESTRONG(TM) Cancer Summit
5. Lance Armstrong Foundation Selects Ogilvy Public Relations Worldwide to Support the LIVESTRONG Global Cancer Campaign
6. Annals of Internal Medicine tip sheet for Aug. 21, 2007, issue
7. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
8. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
9. £5 million investment in personalized medicines to cut patient deaths
10. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
11. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... Baptist ... the U.S. and is the only hospital in the region providing what is ... presentation of transcatheter pacing patients were revealed recently at a medical conference and ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... however, there are professionals who believe that with innovative technologies and under the ... the patient to get the benefit of a dual-approach to his or her ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, ... vast improvements in scientific research and discoveries, leading us to better understand the ... relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition of “World AIDS Day” ...
(Date:12/1/2015)... ... December 01, 2015 , ... The workstation boundaries for imaging ... Information Systems launches MED-TAB™ -- the world’s first portable DICOM-calibrated medical image display, ... to December 4, 2015. , MED-TAB is expected to change teleradiology because ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... radiographic technicians must mark the film for accurate interpretation by the radiologist. The ... Fortunately, an inventor from Sacramento, Calif., has found a way to alleviate this ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... India , December 1, 2015 ... market research report "Immunotherapy Drugs Market by Type of Drug ... Checkpoint Inhibitors), Epidemiology, Regulatory and Pipeline Analysis - Global Forecast ... is poised to reach USD 73,529.2 Million by 2020 from ... from 2015 to 2020. Browse 37 ...
(Date:12/1/2015)... , 1 de diciembre de 2015 /PRNewswire/ ... para cuchillas de precisión, develó hoy un ... identidad de marca. El nuevo logo destaca ... y la ingeniería de productos con cuchillas ... ...
(Date:12/1/2015)... 2015 During the recent 2015 Transcatheter ... Francisco, CA , Medinol Ltd. continued to ... During a satellite symposium, "The BioNIR eDES: The ... Restenosis", a renowned physician panel discussed the key ... Coronary Stent System and the Medinol eDES Coronary ...
Breaking Medicine Technology: